The objective of the current project is to define patients', health care professionals' and 'the society's' preferences for the acceptable risk of antibiotic resistance development for a given increase in mortality, morbidity and/or inconvenience. Patient's preferences can be assessed and expressed in quantitative terms known as utilities. Patients' utilities will enable to weight statistical probabilities for various outcomes according to patients' preferences for these outcomes.